Movano (NASDAQ:MOVE) Given Speculative Buy Rating at Benchmark

Benchmark reaffirmed their speculative buy rating on shares of Movano (NASDAQ:MOVE) in a research report sent to investors on Wednesday, Benzinga reports. Benchmark currently has a $2.00 target price on the technology company’s stock.

Movano Stock Performance

Shares of NASDAQ MOVE opened at $0.31 on Wednesday. Movano has a 1 year low of $0.24 and a 1 year high of $1.25. The firm’s 50 day moving average price is $0.35 and its 200 day moving average price is $0.42. The firm has a market cap of $30.03 million, a P/E ratio of -0.55 and a beta of 0.12.

Institutional Trading of Movano

Hedge funds have recently bought and sold shares of the company. Dorsey & Whitney Trust CO LLC boosted its holdings in shares of Movano by 50.0% in the 2nd quarter. Dorsey & Whitney Trust CO LLC now owns 5,630,084 shares of the technology company’s stock valued at $1,548,000 after purchasing an additional 1,876,000 shares during the last quarter. Mirador Capital Partners LP boosted its holdings in shares of Movano by 9.6% in the 1st quarter. Mirador Capital Partners LP now owns 413,204 shares of the technology company’s stock valued at $170,000 after purchasing an additional 36,230 shares during the last quarter. EP Wealth Advisors LLC acquired a new position in shares of Movano in the 4th quarter valued at $101,000. Finally, Quantum Private Wealth LLC boosted its holdings in shares of Movano by 113.8% in the 2nd quarter. Quantum Private Wealth LLC now owns 89,139 shares of the technology company’s stock valued at $25,000 after purchasing an additional 47,441 shares during the last quarter. Institutional investors and hedge funds own 16.64% of the company’s stock.

About Movano

Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.